Ex parte LUDWIG et al. - Page 6




              Appeal No. 1997-0160                                                                                         
              Application No. 08/073,985                                                                                   


                                                                                                                          
                     Hogan describes preparing genus and species-specific hybridization probes for                         
              detection and/or quantitation of bacteria by comparing one or more sequenced rRNA                            
              variable regions from a target bacteria to one or more rRNA variable region sequences                        
              from closely related bacteria to select a sequence unique to the rRNA of the target                          
              bacteria (p. 9, l. 29 - p. 10, l. 2; p. 30, ll. 4-15).                                                       
                     Frohman describes production of full-length cDNA clones of low abundance                              
              mRNAs by using the DNA polymerase chain reaction to obtain copies of the region                              
              between a single point in the transcript and the 3' or 5' end.                                               
                     According to the examiner,                                                                            
                     it would have been obvious ... to have used primers which amplified just such                         
                     variable regions as identified by Hogan ..., and to have performed                                    
                     subsequent hybridization reactions as taught by Mullis ..., where specific                            
                     probes are used. Just such probes are suggested by Mullis ..., and taught                             
                     explicitly by Hogan ..., and Frohman ... .  While the prior art does not explicitly                   
                     state that the primers used were lacked 3' complementarity to non-target                              
                     nucleic acid sequences, ... such a limitation does not render the claimed                             
                     invention non-obvious but rather, is considered an obvious design                                     
                     component to primer design (answer, para. bridging pp. 9-10).                                         
                     We have no doubt that the prior art could be modified in the manner proposed by                       
              the examiner, however the fact that the prior art could be so modified would not have made                   
              the modification obvious unless the prior art suggested the desirability of the modification.                
              In re Gordon, 733 F.2d 900, 902, 221 USPQ 1125, 1127 (Fed. Cir. 1984).  Here, we                             
              agree with appellants that the examiner has not established a prima facie case of                            

                                                           - 6 -                                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007